ES2062887T3 - Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno. - Google Patents

Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.

Info

Publication number
ES2062887T3
ES2062887T3 ES92903034T ES92903034T ES2062887T3 ES 2062887 T3 ES2062887 T3 ES 2062887T3 ES 92903034 T ES92903034 T ES 92903034T ES 92903034 T ES92903034 T ES 92903034T ES 2062887 T3 ES2062887 T3 ES 2062887T3
Authority
ES
Spain
Prior art keywords
hpv39
genome
papilomavirus
application
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92903034T
Other languages
English (en)
Spanish (es)
Inventor
Gerard Orth
Christoph Volpers
Rolf E Streeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Pasteur
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Institut Pasteur filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2062887T3 publication Critical patent/ES2062887T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/084—Papillomaviridae (F); Polyomaviridae (F), e.g. SV40, BK virus or JC virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES92903034T 1990-12-20 1991-12-20 Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno. Expired - Lifetime ES2062887T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9016044A FR2670797A1 (fr) 1990-12-20 1990-12-20 Sequences d'adn determinees derivees du genome du papillomavirus hpv39, application de ces sequences au diagnostic in vitro d'infection par ce papillomavirus, et a la production de composition immunogene.

Publications (1)

Publication Number Publication Date
ES2062887T3 true ES2062887T3 (es) 1994-12-16

Family

ID=9403488

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92903034T Expired - Lifetime ES2062887T3 (es) 1990-12-20 1991-12-20 Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.

Country Status (10)

Country Link
US (2) US5656423A (https=)
EP (1) EP0563255B1 (https=)
JP (1) JP3859696B2 (https=)
AT (1) ATE112316T1 (https=)
CA (2) CA2098819C (https=)
DE (1) DE69104380T2 (https=)
DK (1) DK0563255T3 (https=)
ES (1) ES2062887T3 (https=)
FR (1) FR2670797A1 (https=)
WO (1) WO1992011369A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
MXPA01004287A (es) * 1998-10-26 2002-06-04 Ventana Med Syst Inc Deteccion del virus del papiloma humano en frotis de papanicolau (pap).
US7569344B2 (en) * 1998-10-26 2009-08-04 Ventana Medical Systems, Inc. Detection of human papilloma virus in papanicolaou (Pap) smears
WO2000061804A1 (en) * 1999-04-14 2000-10-19 Musc Foundation For Research Development Tissue-specific and pathogen-specific toxic agents and ribozymes
US20060275784A1 (en) * 1999-10-26 2006-12-07 Ventana Medical Systems, Inc. Detection of Human Papilloma Virus in Papanicolaou (Pap) Smears
US20040229298A1 (en) * 2000-11-11 2004-11-18 Lu Peter S. Methods and compositions for treating cervical cancer
US7312041B2 (en) * 2001-02-16 2007-12-25 Arbor Vita Corporation Methods of diagnosing cervical cancer
EP1417353A4 (en) * 2001-07-20 2005-08-03 Univ Texas METHODS AND COMPOSITIONS ASSOCIATED WITH HPV ASSOCIATED PENCILS AND CANNULAR WELLS, INCLUDING CIN
US7704965B2 (en) * 2002-06-26 2010-04-27 The Penn State Research Foundation Methods and materials for treating human papillomavirus infections
BR0314155A (pt) 2002-09-09 2005-07-05 Arbor Vita Corp Métodos para diagnosticar câncer cervical
WO2005030041A2 (en) 2003-09-25 2005-04-07 Third Wave Technologies, Inc. Detection of hpv
JP5030594B2 (ja) * 2003-12-23 2012-09-19 アルボー ビータ コーポレーション Ｈｐｖの発癌性株に対する抗体およびそれらの使用方法
DE602005022759D1 (de) 2004-12-08 2010-09-16 Gen Probe Inc Nukleinsäuredetektion aus verschiedenen typen des humanen papillomavirus
AU2005313858B2 (en) * 2004-12-10 2011-04-07 Genera Biosystems Limited Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
US7972776B2 (en) * 2005-11-15 2011-07-05 Oncohealth Corporation Protein chips for HPV detection
US7732166B2 (en) * 2005-11-15 2010-06-08 Oncohealth Corporation Detection method for human pappilomavirus (HPV) and its application in cervical cancer
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
US8968995B2 (en) * 2008-11-12 2015-03-03 Oncohealth Corp. Detection, screening, and diagnosis of HPV-associated cancers
US20100003704A1 (en) * 2008-06-13 2010-01-07 Shuling Cheng IN SITU detection of early stages and late stages HPV infection
AU2008236678B2 (en) * 2007-04-05 2013-09-12 Genera Biosystems Limited Compositions and methods of detection
GB0820822D0 (en) * 2008-11-13 2008-12-24 Inst Catala D Oncologia Novel product and processes
EP2427763A4 (en) 2009-05-07 2013-08-21 Oncohealth Corp IDENTIFICATION OF A HIGH CIN2 DEGREE FOR THE DETECTION OF EARLY AND LATE TADIES AND FOR THE SCREENING AND DIAGNOSIS OF HUMAN PAPILLOMA (HPV) AND ASSOCIATED CANCER DISORDERS
WO2011084598A1 (en) 2010-01-08 2011-07-14 Oncohealth Corporation High throughput cell-based hpv immunoassays for diagnosis and screening of hpv-associated cancers
JP6153866B2 (ja) * 2010-05-25 2017-06-28 キアゲン ガイサーズバーグ アイエヌシー． 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593828B2 (fr) * 1986-01-31 1990-05-04 Pasteur Institut Sonde a papillomavirus et procede de diagnostic in-vitro d'infections a papillomavirus
FR2629458B2 (fr) * 1987-07-31 1991-08-09 Ire Celltarg Sa Nouvelles sondes d'acides nucleiques specifiques de differents types de virus de papillome humain
US5182377A (en) * 1988-09-09 1993-01-26 Hoffmann-La Roche Inc. Probes for detection of human papillomavirus
US5447839A (en) * 1988-09-09 1995-09-05 Hoffmann-La Roche Inc. Detection of human papillomavirus by the polymerase chain reaction
FR2641081A1 (https=) * 1988-12-23 1990-06-29 Medgenix Group

Also Published As

Publication number Publication date
JPH06504672A (ja) 1994-06-02
JP3859696B2 (ja) 2006-12-20
CA2375673A1 (fr) 1992-07-09
DE69104380D1 (de) 1994-11-03
US5656423A (en) 1997-08-12
FR2670797A1 (fr) 1992-06-26
WO1992011369A1 (fr) 1992-07-09
ATE112316T1 (de) 1994-10-15
EP0563255A1 (fr) 1993-10-06
CA2098819A1 (fr) 1992-06-21
CA2098819C (fr) 2002-06-18
DK0563255T3 (da) 1994-10-24
EP0563255B1 (fr) 1994-09-28
DE69104380T2 (de) 1995-02-09
US5665535A (en) 1997-09-09
CA2375673C (fr) 2005-05-17
FR2670797B1 (https=) 1994-08-19

Similar Documents

Publication Publication Date Title
ES2062887T3 (es) Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.
DK605987D0 (da) Bestemte dna-sekvenser afledt af et papillomavirus-genom, deres anvendelse til in vitro diagnoseformaal og fremstilling af antigeniske praeparater
CY1110716T1 (el) Πολλαπλασιασμος ιων εντος κυτταροκαλλιεργειας
HUP0202639A2 (en) Immunostimulatory nucleic acids
MY104590A (en) Improvements in or relating to organic compounds.
ES2129386T1 (es) Vacuna contra influenza.
EP1715064A8 (fr) Séquences nucléotidiques issues du génome des rétrovirus du type HIV-1, HIV-2 et SIV, et leurs applications notamment pour l'amplification des génomes de ces rétrovirus et pour le diagnostic in vitro des infections dûes à ces virus
ATE434035T1 (de) Lebender influenza impfstoff und verfahren zu seiner herstellung
DK0750672T3 (da) DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
GR3022248T3 (en) Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses
DK1334119T3 (da) Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet
DE69627526D1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
ATE408013T1 (de) Infektiöses cdna klon des gb-virus b und dessen verwendungen
ES2054230T3 (es) Un proceso para la preparacion de un enterovirus o rinovirus atenuado.
EE200200157A (et) Vaktsiin
DK76688D0 (da) Vaccine indeholdende f-proteinet fra aids-virus
ATE107361T1 (de) Gen des hüllproteins des gurkenmosaikvirus.
DK0540525T3 (da) Fremgangsmåde til fremstilling af vacciner og anvendelse af de således fremstillede vacciner
AR021143A1 (es) Identificacion de genotipos senv
MY104975A (en) Protease, reverse transcriptase and endonuclease of retrovirus, and method for producing these enzymes.
EP1309342A4 (en) PREPARATION OF A CHIMERIC PAPILLOMA VIRUS (22.01.2)
DK631387A (da) Virusvektor
WO2003072750A3 (en) Expression of hiv-related proteins in plants
AP1561A (en) Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection.
ATE237616T1 (de) Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563255

Country of ref document: ES